Understanding how common persistent cough is in work-related lung disease
| ISRCTN | ISRCTN10790205 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN10790205 |
| IRAS number | 258563 |
| Secondary identifying numbers | IRAS 258563 |
- Submission date
- 25/08/2023
- Registration date
- 04/12/2023
- Last edited
- 04/12/2023
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Respiratory
Plain English summary of protocol
Background and study aims
This is a questionnaire study aimed at identifying the presence and severity of cough in patients attending occupational lung clinics. Persistent coughing has been associated with many occupational and environmental substances (e.g. flour, dust), however the prevalence and severity of cough in this population is unknown. In order to understand the reasons for cough in these patients and develop effective therapies, it is important to first understand the scale of the problem.
Patients attending the occupational clinic as part of their routine care will be asked if they are interested in taking part in a questionnaire study, they will be given the patient information sheet and allowed time to read and ask questions.
Their written consent will be obtained prior to administration of the questionnaires. Following the collection of their demographics and questionnaire completion, the participant will have completed the study. Their notes will be checked at a later date to obtain their final respiratory diagnosis.
Who can participate?
Any patient with a work-related lung condition, who has had a persistent cough for greater than 8 weeks.
What does the study involve?
Questionnaires about their health and cough symptoms.
What are the possible benefits and risks of participating?
There are no risks to taking part, the study is simply a questionnaire with no sensitive information collected. There are no direct benefits to individuals taking part, however, this study may help us understand important symptoms and aid us to better treating patients in the future.
Where is the study run from?
Manchester University NHS Foundation Trust (UK)
When is the study starting and how long is it expected to run for?
March 2021 to April 2025
Who is funding the study?
North West Lung Charity (UK)
Who is the main contact?
Dr Huda Badri
huda.badri@manchester.ac.uk
Contact information
Principal Investigator
Level 2 Education and Research Centre
Wythenshawe hospital
Manchester
M23 9LT
United Kingdom
 ORCID ID |
0000-0002-6134-4347 |
|---|---|
| Phone | +44 161 291 5031 |
| huda.badri@manchester.ac.uk |
Study information
| Study design | Single centre observational study |
|---|---|
| Primary study design | Observational |
| Secondary study design | Cohort study |
| Study setting(s) | Hospital |
| Study type | Other |
| Participant information sheet | 44186 COLD study PIS V1.1 17April2023.pdf |
| Scientific title | Cough in Occupational Lung Disease |
| Study acronym | COLD |
| Study objectives | Chronic cough is a troublesome condition that is defined by the presence of cough for >8 weeks. Neuronal dysfunction is now a recognised mechanism of refractory chronic cough. A wide variety of occupational lung conditions have recognised potential causes or exacerbating factors in persistent cough. Current guidelines now recommend screening employed patients for potential occupational and environmental causes of cough. However, the prevalence of persistent cough in the occupational lung disease population is unknown. Chronic cough can be detrimental to the wellbeing of patients and there are no effective licensed therapies. Thus, early identification of patients with an occupational cause of persistent coughing is vital, as it can be necessary to alter their work environment or remove them from that workplace in order to treat them effectively. Various studies have suggested that there are both direct and indirect mechanisms of occupational agents that can precipitate cough, e.g. stimulation of airway nerves and cough receptors by particulates such as construction dust, allergic inflammation from environmental allergens leading to inflammatory mediator release causing cough. This research forms part of the initial exploratory work into potential neuronal mechanisms of occupation-induced cough and asthma. In order to develop studies to identify and investigate these mechanisms, we need to understand the patient demographics and identify the prevalence and severity of cough in this patient group. Aim: To identify the prevalence of chronic cough in patients attending a specialist occupational lung clinic and to measure the effect of cough on their quality of life. |
| Ethics approval(s) |
Approved 10/05/2023, Cambridge South (Equinox House, City Link, Nottingham, NG2 4LA, United Kingdom; +44 207 104 8084; cambridgesouth.rec@hra.nhs.uk), ref: 23/EE/0088 |
| Health condition(s) or problem(s) studied | Occupational lung diseases (airways and pneumoconiosis) |
| Intervention | Once consented, participant demographics and whether they report a chronic cough will be recorded and the participant will be asked to complete the Leicester Cough Questionnaire and a Visual Analogue Scale (VAS), which involved putting a mark on a 100-mm line to rate how severe their cough is. This is the end of the participant involvement, although their final diagnosis will be recorded once it is available in the participant's hospital records. |
| Intervention type | Other |
| Primary outcome measure | The presence of a chronic cough at the clinic visit, as determined by asking the participant. |
| Secondary outcome measures | 1. Leicester Cough Questionnaire score at the clinic visit. 2. Cough severity VAS score at the clinic visit. 3. Participant diagnosis, as determined by medical records following the clinic visit. 4. Participant demographics as recorded at the clinic visit. |
| Overall study start date | 22/03/2021 |
| Completion date | 01/04/2025 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Upper age limit | 80 Years |
| Sex | Both |
| Target number of participants | 100 |
| Key inclusion criteria | 1. Patients aged 18 years and over, up to the age of 80. 2. Suspected/ confirmed occupational lung disease 3. Able to read English to allow for completion of written questionnaires |
| Key exclusion criteria | 1. Patients currently receiving ACE inhibitors. 2. Patients presenting with a cough of ≤8 weeks duration. |
| Date of first enrolment | 01/10/2023 |
| Date of final enrolment | 01/10/2024 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Oxford Road
Manchester
M13 9WL
United Kingdom
Sponsor information
Hospital/treatment centre
Research Office
1st Floor Nowgen Building
Manchester
M13 9WU
England
United Kingdom
| Phone | +44 161 276 3340 |
|---|---|
| lynne.webster@mft.nhs.uk | |
| Website | https://mft.nhs.uk/ |
"ROR" |
https://ror.org/00he80998 |
Funders
Funder type
Charity
No information available
Results and Publications
| Intention to publish date | 01/04/2026 |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Data sharing statement to be made available at a later date |
| Publication and dissemination plan | Planned publication in a high-impact peer-reviewed journal |
| IPD sharing plan | The current data sharing plans for this study are unknown and will be available at a later date |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | version 1.1 | 17/04/2023 | 01/11/2023 | No | Yes |
Additional files
Editorial Notes
01/11/2023: Trial's existence confirmed by NHS HRA.
